We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Active vitamin D analog and SARS‐CoV‐2 IgG after BNT162b2 vaccination in patients with hemodialysis: Correspondence.
- Authors
Daungsupawong, Hinpetch; Wiwanitkit, Viroj
- Abstract
This article discusses a study that examined the relationship between active vitamin D analogs and SARS-CoV-2 IgG levels in hemodialysis patients who received the BNT162b2 COVID-19 vaccine. The study found that the use of active vitamin D analogs was associated with increased levels of SARS-CoV-2 IgG after vaccination. However, the study had some limitations, including the absence of a control group and the reliance on self-reported medication use. The authors suggest that future randomized controlled trials could provide stronger evidence of causality and further investigate the impact of vitamin D on immune responses to the COVID-19 vaccine.
- Subjects
COVID-19; SARS disease; VITAMIN D; COVID-19 pandemic; IMMUNOGLOBULIN G
- Publication
Therapeutic Apheresis & Dialysis, 2024, Vol 28, Issue 5, p810
- ISSN
1744-9979
- Publication type
Article
- DOI
10.1111/1744-9987.14171